Compare Manhattan Associates Inc (MANH) vs Mesoblast Limited (MESO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Manhattan Associates Inc vs Mesoblast Limited — how do they compare? Manhattan Associates Inc trades at $189.84 (market cap $11.38B), while Mesoblast Limited trades at $17.03 (market cap $2.21B). The key difference: Manhattan Associates Inc is far larger — about 5.1× Mesoblast Limited's market cap, and Manhattan Associates Inc is trading nearer its 52-week high, Mesoblast Limited nearer its low. Which is the better fit depends on your goals.
| MANH | MESO | |
|---|---|---|
Market Cap | $11.38B | $2.21B |
Sector | Technology | Technology |
52-Week High | $220.19 | $20.96 |
52-Week Low | $120.88 | $12.88 |
Enterprise Value | $11.25B | $2.21B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Manhattan Associates Inc
Manhattan Associates, Inc. is a global leader in supply chain and omnichannel commerce software. The company provides a comprehensive suite of cloud-based and on-premise solutions for warehouse management (WMS), transportation management (TMS), and order management (OMS). MANH's technology helps retailers, wholesalers, and manufacturers manage inventory, optimize logistics, and unify the shopping experience across physical and digital channels.
Read more on MANH →About Mesoblast Limited
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →
